FDA EIR - Didion Milling, Inc. - March 05, 2019

An FDA inspection was conducted at Didion Milling, Inc. in Cambria, WI, on March 5, 2019. This assessment focused on ensuring adherence to Good Manufacturing Practices (GMP) for milled grain products. The company was in the midst of significant reconstruction efforts, having been non-operational since a major plant explosion in May 2017. At the time of the inspection, no manufacturing for human consumption was actively taking place, though limited operations were expected to resume shortly. The inspection involved a comprehensive walk-through of both the completed and under-construction areas of the facility. The FDA investigator found no significant objectionable conditions or compliance deficiencies. As a result, no "Inspectional Observations" (FDA Form 483) were issued, and Didion Milling, Inc. received no specific recommendations for corrective actions. The positive outcome indicates the company's commitment to maintaining regulatory standards, even while rebuilding its capacity to produce various corn-based products, including those for government food aid programs.